TM

Trevor Martin

Founder of Mammoth Biosciences

San Francisco, California

Overview 

Trevor Martin is the Co-Founder and CEO of Mammoth Biosciences, a company focused on developing the next generation of CRISPR therapies. With a PhD from Stanford University and experience as an undergraduate researcher at Princeton University, he has successfully led Mammoth Biosciences and invested in companies like Plantible Foods at the Series A stage.

Work Experience 

MB

Mammoth Biosciences

  • Co-Founder and CEO

    2017 - Current

    Building the CRISPR platform for the next generation of potentially curative therapies and beyond.

Mammoth Biosciences develops novel CRISPR applications for disease detection, research, agriculture, biodefense, and more.

Raised $264,545,000.00 from Bradley Horowitz, Plum Alley, Decheng Capital, Senator Investment Group, Redmile Group, Sixth Street, Foresite Capital, NFX, Tachyon Ventures and Mayfield Fund.

mammoth.bio
SU

Stanford University

  • Graduate Student

    2011 - 2017

    Research concerning genetics and statistics in Fraser Lab at Stanford University

PU

Princeton University

  • Undergraduate Researcher, Storey Lab

    2008 - 2011

    • Conducted independent research in quantitative biology • Main project involved developing and applying novel statistical methods to genomic data in order to understand environment specific regulation of gene expression, which has implications for drug design, personalized genomics, and is a little understood aspect of essential biology • Tested quantitative results through laboratory work including quantitative PCR and in vivo allele swaps

Education 

Investments 

Plantible Foods

Series A

Total funding: $22M

Articles About Trevor

Relevant Websites